Results 231 to 240 of about 1,864,473 (295)

Adaptations of glucagon‐like peptide‐1 receptor agonist‐induced weight loss, drivers of weight regain and future directions of therapeutics

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend During GLP‐1RA treatment reduced appetite and energy intake, delayed gastric emptying, decreased visceral fat mass and improved glycaemic control contribute to weight loss. After treatment cessation these benefits are partially or completely reversed, resulting in weight regain, accompanied by increased appetite and energy intake,
Camille E. M. Piguet   +2 more
wiley   +1 more source

Spontaneous Hyperinflation of Intragastric Balloon Presenting as Acute Pancreatitis

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Obesity is a metabolic disorder with considerable health implications affecting populations worldwide. Intragastric balloon (IGB) placement has gained popularity as a minimally invasive and reversible management option for obesity. Although generally safe, IGBs can sometimes be associated with serious adverse outcomes. We present a case of IGB
Ong Yan Ling   +2 more
wiley   +1 more source

Metabolic Improvement and Weight Reduction After Large Endoscopic Submucosal Dissection Including the Papilla for Duodenal Adenoma: A Case Report

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Endoscopic submucosal dissection (ESD) has become an established therapeutic approach for duodenal adenomas, although it is technically demanding. Duodenal mucosal resurfacing (DMR) is an emerging endoscopic metabolic therapy designed to ablate and regenerate duodenal mucosa. To date, no reports have described ESD including the papilla (ESDIP)
Chi‐Chu Lo   +5 more
wiley   +1 more source

Effects of bariatric surgery on non-invasive markers of MASLD: a retrospective analysis. [PDF]

open access: yesBMC Gastroenterol
Lukolic I   +8 more
europepmc   +1 more source

Serious Adverse Events in Adult ICU Patients: A Substudy of the PATIENCE Cohort

open access: yesActa Anaesthesiologica Scandinavica, Volume 71, Issue 1, January 2027.
ABSTRACT Introduction Prokinetic agents are used to enhance upper gastrointestinal motility, but adverse events related to these agents are poorly described. We aimed to provide detailed epidemiological data on predefined serious adverse events (SAEs) in a cohort of adult intensive care unit (ICU) patients with and without prokinetic treatment.
Vera Crone   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy